UNI VERSI TAS SUMATERA UTARA
DAFTAR PUSTAKA
1. Pradeep,A,MD.ChronicKidneyDisease.MedscapeDrugs&Diseases.(2014).Retri evedfrom. http://emedicine.medscape.com/article/238798-overview-a0156.
2. CDC. Prevalence of Chronic Kidney Disease and Associated Risk Factors. United states: Center for Disease Control and Prevention. 2007.Available from: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5608a2.htm
3. Coresh, J. et al., Prevalence of Chronic Kidney Disease in the United States. JAMA 2007;298(17):2038-2047
4. Thomas, R., A. Kanso and J.R. Sedor. Chronic Kidney Disease and Its Complication. Prim Care (2008); 35(2): 329-vii
5. World Health Organization. Reducing Risks, Promoting Healthy Life. 2002. Available from: http://www.who.int/whr/2002/en/whr02_en.pdf?ua=1
6. Prodjosudjadi, W., A. Suhardjono. End-Stage Renal Disease in Indonesia: Treatment Development. Ethn Dis.2009;19(suppl1):S1-33S1-36
7. Triyanti, K., Suhardjono, P. Soewondo, H. Shatri Renal Function Decrement in Type 2 Diabetes Mellitus Patient in Cipto Mangunkusumo Hospital. Acta Med Indones 2008;40(4) :192-200
8. Fauci et al.Chronic Kidney Disease. in: Harrison’s Principles of Internal Medicine 18th Edition. New York, U.S.A.:The McGraw-Hill Companies.2012:2308-2321
9. Sinabariba, R. Karakteritik Penderita GGK Rawat Inap di RSUP. H. Adam Malik Medan Tahun 2000-2001. Skripsi Mahasiswa. FKM USU, Medan. 2002.
10. Suwitra, Ketut. Penyakit Ginjal Kronik. Dalam : Sudoyo, Aru W dkk (editor). Buku Ajar Ilmu Penyakit Dalam. Internal Publishing, Jakarta, Indonesia 2009 hal :1035-1040.
11. Siallagan H. Karakteristik Penderita Gagal Ginjal Kronik (GGK) Yang Dirawat Inap di RS Martha Friska Medan Tahun 2011.Skripsi Mahasiswa FKM USU, Medan. 2012.
UNI VERSI TAS SUMATERA UTARA 13. Ginting, F. L. Karakteristik Penderita Gagal Ginjal Kronik (GGK) Yang.
Dirawat Inap di Rumah Sakit Umum Pusat Haji Adam Malik Medan Tahun 2007.Skripsi Mahasiswa FKM USU,Medan. 2008.
14. Romauli. Karakteristik Penderita Gagal Ginjal Kronik (GGK) Yang Dirawat inap di Rumah Sakit Umum Daerah Dr. H. Kumpulan Pane Tebing Tinggi Tahun 2007-2008. Skripsi Mahasiswa FKM USU, Medan. 2009.
15. PERNEFRI. Penyakit Ginjal Kronik & Glomerulopati: Aspek Klinik & Patologi Ginjal & Pengelolaan Hipertensi Saat Ini JNHC. PERNEFRI. 2003.
16. Roesli, R. Hipertensi, Diabetes, dan Gagal Ginjal di Indonesia. Dalam: Lubis, F.R., et al (eds). 2008. Hipertensi dan Ginjal. USU Press, Medan:2008 95-108.
17. Sukandar, E. Nefrologi Klinik Edisi III. Bandung: Fakultas Kedokteran UNPAD.2006
18. Chen Wei, Lm Q, Wang H, Chen Weiqmg, Johnson RJ, Dong X, Li H, Ba S, Tan J, Luo N. He H, Yu H. Prevalence and risk faktor of chronic kidney disease : a population study in the Tibetan population. Nephrol dial transplant, October 12, 2010.
19. Yamagata K, Ishida K, Sairenchi T , Takashi H, Ohba S, Shiigai T, NaritaM and Koyama A. Risk factor, for chronic kidney disease in a community-based population : a 10-years follow-up study. Kidney International ( 1 January 2007)71,159-166.
20. McClellan William, Flanders WD. Risk Factors of Progressive Chronic Kidney Disease. J Am Soc Nephrol 2003;14: 65-70.
21. Taal MW, Brenner BM : Predicting initiation and progression of chronic kidney disease : Developing renal risk scores. Kidney Int 2006 Nov;70 (10) :694-705.
22. Luke RG. Hypertensive nephrosclerosis : pathogenesis and prevalence. Essential hypertension is an important cause of end-stage renal disease. Nephrol Dial Transplant (1999) 14 : 2271-2278.
23. Elsayed K. Obesity and Chronic Kidney Disease. Arch Item Med 2008; 164 : 249-258.
UNI VERSI TAS SUMATERA UTARA 25. DeFronzo RA, Ferrannini E. Insulin resistance. A Multifaceted syndrome
responsible for NIDDM, obesity, hypertension, dyslipidemia and atherosclerotic cardiovaskular disease. Diabetes care 1991;14:173-194.
26. Wahba IM, Mak RH. Obesity and Obesity-Initiated Metabolic Syndrome: Mechanistic Link to Chronic Kidney Disease. Clin J Am Soc Nephrol 2007;2 : 550-562.
27. Grassi, G., Seravalle, G., Calhoun, D.A., Bolla, G.B., Giannattasio, C.G., Marabini, M., Del Bo, A., Mansia, G. Mechanisms responsible for sympathetic activation by cigarret smoking in humans; Circulation 1994; 90 : 248-253.
28. Orth, S.R., Ogata, H., Ritz, E. Smoking and kidney; Nephrol Dial Transplant 2000; 15:1509-1511.
29. Levey, A., S., Coresh, J., Balk, E., Kaustz, A.T., Lavin, A. National Kidney Foundation Practice Guidelines For Chronic Kidney Disease. Evaluasi Klasifikasi and Stratification ; Ann Intern Med 2003; 139, 137, 147.
30. Alexander, R.T. dkk. Kidney Stone and Kidney fuction loss: a Cohort Study. BMJ 2012;243.
31. Rule, A.D., A.E. Krambeck and J.C. Lieke. Chronic Kidney Disease in Kidney Stone Formers. Clin J Am Soc Nephrol (2011)6:2069-2075.
32. Sukandar, Enday. Infeksi Saluran Kemih Pasien Dewasa. Dalam Sudoyo, Aru W dkk (editor). Buku Ajar Ilmu Penyakit Dalam. Internal Publishing, Jakarta, Indonesia 2009 hal : 1008.
33. Smith, Edwin A. Pyelonephritis, Renal Scarring, and Reflux Nephropathy : A Pediatris Urologist’s Perspective Pediatr Radiol (2008) 38 (suppl 1 :s76- s82.
34. Price, S.A. Patofisiologi, Konsep Klinis Proses-Proses Penyakit. Buku II. Edisi 4. EGC, Jakarta; 1995.
35. Choi, G.R. Genetic Variation of The Apo AI-CII-AIV Gene Cluster In Hypertriglycerimedic Patients with Chronic Renal Failure Undergoing Hemodialysis. Journal of Korean Medical Science. 2000;Vol. 15. No.3.
UNI VERSI TAS SUMATERA UTARA 37. Suwitra K. Penyakit Ginjal Kronik. Dalam: Sudoyo AW, Setiyohadi B, Alwi
I, Simadibrata K M, Setiati S, editor. Buku Ajar Ilmu Penyakit Dalam jilid I. Jakarta: Balai Penerbit FKUI, 2006;570.
38. Rahardjo P, Susalit E, dan Suhardjono. Hemodialisis. Dalam: Sudoyo AW, Setiyohadi B, Alwi I, Simadibrata K M, Setiati S, editor. Buku Ajar Ilmu Penyakit Dalam jilid I. Jakarta: Balai Penerbit FKUI,2006; 579-580
39. Susalit, E., 2003. Rekomendasi Baru Penatalaksanaan Penyakit Ginjal Kronik. In: Penyakit Ginjal Kronik & Glomerulonepati: Aspek Klinik &Patologi Gnjal Pengelolaan Hipertensi Saat Ini. Perhimpunan Nefrologi Indonesia. Jakarta: 1-8
40. Hsu, C., Culloch, C.E., Darbinian, J., Go, A.S., Tribarren, C., 2005. Elevated blood pressure and risk of end stage renal disease in subjects wwithout baseline kidney disease, Arch Interrn Med, 165:923-928
41. Afolabi MO, Abloye-Kuteyl EA, Arogundade FA, Bello. Prevalence of Chronic Kidney Disease in a Nigerian Family Practice Populatian. SA Farm Pract 2009; 51(2):132-137
42. Amato, D., C.A. Aguilar, R.C. Limones, E.Rodriguez,M.A. Diaz, F.Arreola dkk. Prevalence of Chronic Kidney Disease in Urban Mexican Population.Kidney International, Vol.68. Sepplement 97(2005), pp.S11-S17
43. Rasic, S., A. Arna, S. Unicanin, J. Dzemidzic, D. Rebic, A. Muslimovic et al. Long-Term Outcome of Patients with Lupus Nephritis: a Single Center Experience.Bosnian journal of basic medical sciences (2010);10:S63-S67
44. Prodjosujadi.W. Incidence, Prevalence, Tratment and Cost of End-Stage Renal Diseare in Indonesia. Ethnicity&Disease 2006:16
45. Vupputuri,S.,Soucie,J.M., McClellan,W., Sandler,D.P.2004.History of kidneystones as a possible risk factor for chronic kidney disease.Ann Epidemiol14:222–228
46. Saucier, N.A., Sinha, M.K., Liang, K.V., Krambeck, A.E., Weaver, A.L., Bergstralh, E.J.,et al. 2010. Risk Factor for Chronic Kidney Disease in Person with Kidney Stone.Am J Kidney Dis. 55: 61-68
UNI VERSI TAS SUMATERA UTARA 48. Chadban, S.J, E.M. Briganti, P.G. Kerr, D.W. Dunstan, T.a. Welborn, P.Z.
